

[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
Brian Abrahams Reiterated (SRPT) at Buy and Held Target at $181 on, Aug 15th, 2024
Brian Abrahams of RBC Capital, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $181 on, Aug 15th, 2024.
Brian has made no other calls on SRPT in the last 4 months.
There are 14 other peers that have a rating on SRPT. Out of the 14 peers that are also analyzing SRPT, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Hoang of "Citigroup" Maintained at Hold with Decreased Target to $160 on, Thursday, August 8th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $152 on, Thursday, August 8th, 2024
These are the ratings of the 12 analyists that currently disagree with Brian
- Gavin Clark-Gartner of "Evercore ISI Group" Upgraded from Hold to Buy and Decreased Target to $179 on, Thursday, August 8th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $203 on, Thursday, August 8th, 2024
- Biren Amin of "Piper Sandler" Maintained at Buy with Decreased Target to $200 on, Thursday, August 8th, 2024
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $235 on, Thursday, June 27th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Mani Foroohar of "Leerink Partners" Maintained at Buy with Increased Target to $230 on, Monday, June 24th, 2024
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $213 on, Friday, June 21st, 2024
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, June 21st, 2024
- Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
- Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
Contributing Sources